DK1143997T3 - Tumor nekrose faktor antagonister og deres anvendelse i behandling af endometriosis - Google Patents

Tumor nekrose faktor antagonister og deres anvendelse i behandling af endometriosis

Info

Publication number
DK1143997T3
DK1143997T3 DK00900306T DK00900306T DK1143997T3 DK 1143997 T3 DK1143997 T3 DK 1143997T3 DK 00900306 T DK00900306 T DK 00900306T DK 00900306 T DK00900306 T DK 00900306T DK 1143997 T3 DK1143997 T3 DK 1143997T3
Authority
DK
Denmark
Prior art keywords
endometriosis
treatment
necrosis factor
tumor necrosis
factor antagonists
Prior art date
Application number
DK00900306T
Other languages
English (en)
Inventor
Francesco Borrelli
Antonio Mauro D
Fabrizio Martelli
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8237393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1143997(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK1143997T3 publication Critical patent/DK1143997T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00900306T 1999-01-22 2000-01-19 Tumor nekrose faktor antagonister og deres anvendelse i behandling af endometriosis DK1143997T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99101194A EP1022027A1 (en) 1999-01-22 1999-01-22 Tumor necrosis factor antagonists and their use in endometriosis
PCT/IB2000/000052 WO2000043031A1 (en) 1999-01-22 2000-01-19 Tumor necrosis factor antagonists and their use in endometriosis

Publications (1)

Publication Number Publication Date
DK1143997T3 true DK1143997T3 (da) 2003-09-15

Family

ID=8237393

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00900306T DK1143997T3 (da) 1999-01-22 2000-01-19 Tumor nekrose faktor antagonister og deres anvendelse i behandling af endometriosis

Country Status (30)

Country Link
US (2) US6663865B1 (da)
EP (2) EP1022027A1 (da)
JP (1) JP4601176B2 (da)
KR (2) KR100685106B1 (da)
CN (2) CN1212152C (da)
AR (1) AR022251A1 (da)
AT (1) ATE242002T1 (da)
AU (1) AU771964B2 (da)
BG (1) BG65556B1 (da)
BR (1) BR0008182A (da)
CA (1) CA2356737C (da)
CZ (1) CZ302866B6 (da)
DE (1) DE60003152T2 (da)
DK (1) DK1143997T3 (da)
EA (1) EA003927B1 (da)
EE (1) EE05543B1 (da)
ES (1) ES2200808T3 (da)
HK (1) HK1043059B (da)
HU (1) HU226149B1 (da)
IL (2) IL144413A0 (da)
NO (1) NO328814B1 (da)
NZ (1) NZ512585A (da)
PL (1) PL204713B1 (da)
PT (1) PT1143997E (da)
SI (1) SI1143997T1 (da)
SK (1) SK287313B6 (da)
TR (1) TR200102107T2 (da)
UA (1) UA78483C2 (da)
WO (1) WO2000043031A1 (da)
ZA (1) ZA200105263B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100857376B1 (ko) * 2001-01-29 2008-09-05 라보라토리스 세로노 에스.에이. 심장 질환의 치료 및/또는 예방에 사용되는 ｉｌ-18저해물질
US20050271663A1 (en) * 2001-06-28 2005-12-08 Domantis Limited Compositions and methods for treating inflammatory disorders
US20060073141A1 (en) * 2001-06-28 2006-04-06 Domantis Limited Compositions and methods for treating inflammatory disorders
EP1709965A3 (en) 2001-07-11 2006-12-27 Boehringer Ingelheim Pharmaceuticals, Inc. Methods of treating cytokine mediate diseases
US7082134B1 (en) * 2002-01-18 2006-07-25 Juniper Networks, Inc. Redirect checking in a network device
US20070298041A1 (en) * 2002-06-28 2007-12-27 Tomlinson Ian M Ligands That Enhance Endogenous Compounds
US9028822B2 (en) 2002-06-28 2015-05-12 Domantis Limited Antagonists against TNFR1 and methods of use therefor
ATE416783T1 (de) * 2003-02-07 2008-12-15 Austria Wirtschaftsserv Gmbh Verwendung des menschlichen choriongonadotropins in der behandlung von endometriose-symptomen
MXPA06002853A (es) 2003-09-11 2006-06-14 Kemia Inc Inhibidores citoquina.
GB0327112D0 (en) 2003-11-21 2003-12-24 Clincial Designs Ltd Dispenser and reservoir
GB0408449D0 (en) 2004-04-15 2004-05-19 Banerjee Subhasis Diagnostic and therapeutic applications of soluble lhcge protein
CA2565801A1 (en) * 2004-05-28 2005-12-15 Applied Research Systems Ars Holding N.V. Use of il-17 in the treatment of fertility-related disorders
US20060045902A1 (en) * 2004-09-01 2006-03-02 Serbousek Jon C Polymeric wrap for in vivo delivery of osteoinductive formulations
DE202006021081U1 (de) * 2005-07-12 2012-05-08 Dmi Biosciences, Inc. Produkte zur Behandlung von Krankheiten
NZ580530A (en) * 2007-06-06 2012-04-27 Domantis Ltd Anti vegf polypeptides, antibody variable domains and antagonists
DK2326332T3 (da) * 2009-06-22 2013-03-04 Dmi Acquistion Corp Fremgangsmåde til behandling af sygdomme
SG177302A1 (en) * 2009-06-22 2012-02-28 Dmi Acquisition Corp Methods and products for treatment of diseases
CN104968350A (zh) 2012-12-19 2015-10-07 安皮奥制药股份有限公司 疾病的治疗方法
HK1247622A1 (zh) 2015-03-02 2018-09-28 180 Therapeutics Lp 利用il-33拮抗剂来治疗局部纤维化的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037805A (en) * 1989-03-20 1991-08-06 The Salk Institute For Biological Studies Methods of contraception
US20040120952A1 (en) * 2000-08-07 2004-06-24 Centocor, Inc Anti-TNF antibodies and peptides of human tumor necrosis factor
CA2736076A1 (en) * 1991-03-18 1992-09-19 New York University Monoclonal and chimeric antibodies specific for human tumor necrosis factor
EP0620739A4 (en) * 1992-09-15 1997-01-15 Immunex Corp Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists.
US5389657A (en) * 1993-02-01 1995-02-14 Free Radical Sciences Corporation Method for treating infertility
IL111125A0 (en) * 1994-05-11 1994-12-29 Yeda Res & Dev Soluble oligomeric tnf/ngf super family ligand receptors and their use
US5747532A (en) * 1995-11-21 1998-05-05 Medinox, Inc. Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
US6090382A (en) * 1996-02-09 2000-07-18 Basf Aktiengesellschaft Human antibodies that bind human TNFα
US5710247A (en) * 1996-03-19 1998-01-20 Abbott Laboratories Process and intermediates for the synthesis of LHRH antagonists
GB9607120D0 (en) * 1996-04-04 1996-06-12 Chiroscience Ltd Compounds
GB9616643D0 (en) * 1996-08-08 1996-09-25 Chiroscience Ltd Compounds
EP0959897B1 (en) * 1996-11-27 2009-04-22 Immunex Corporation Method of regulating nitric oxide production
US6514977B1 (en) * 1997-05-22 2003-02-04 G.D. Searle & Company Substituted pyrazoles as p38 kinase inhibitors

Also Published As

Publication number Publication date
EP1143997B1 (en) 2003-06-04
UA78483C2 (en) 2007-04-10
PL204713B1 (pl) 2010-02-26
SK10292001A3 (sk) 2001-12-03
SK287313B6 (sk) 2010-06-07
HUP0105103A2 (hu) 2002-04-29
CN1698894A (zh) 2005-11-23
AU1997300A (en) 2000-08-07
CN100594932C (zh) 2010-03-24
JP4601176B2 (ja) 2010-12-22
DE60003152D1 (de) 2003-07-10
AR022251A1 (es) 2002-09-04
SI1143997T1 (en) 2003-12-31
CA2356737A1 (en) 2000-07-27
EA200100799A1 (ru) 2001-12-24
KR20010101397A (ko) 2001-11-14
CZ20012656A3 (cs) 2002-02-13
ZA200105263B (en) 2002-06-26
NO20013577D0 (no) 2001-07-19
EE200100378A (et) 2002-10-15
PL350002A1 (en) 2002-10-21
KR100685106B1 (ko) 2007-02-22
HK1043059B (zh) 2005-11-18
AU771964B2 (en) 2004-04-08
BR0008182A (pt) 2001-11-06
ATE242002T1 (de) 2003-06-15
CZ302866B6 (cs) 2011-12-21
CN1212152C (zh) 2005-07-27
ES2200808T3 (es) 2004-03-16
BG105691A (en) 2002-02-28
BG65556B1 (bg) 2008-12-30
JP2002535284A (ja) 2002-10-22
EE05543B1 (et) 2012-06-15
NO20013577L (no) 2001-08-29
HK1043059A1 (en) 2002-09-06
NZ512585A (en) 2003-08-29
HU226149B1 (en) 2008-05-28
CA2356737C (en) 2010-03-23
EP1143997A1 (en) 2001-10-17
DE60003152T2 (de) 2004-03-25
CN1337883A (zh) 2002-02-27
PT1143997E (pt) 2003-10-31
KR20060128056A (ko) 2006-12-13
HUP0105103A3 (en) 2004-08-30
EA003927B1 (ru) 2003-10-30
IL144413A (en) 2009-05-04
US20040057954A1 (en) 2004-03-25
IL144413A0 (en) 2002-05-23
TR200102107T2 (tr) 2001-12-21
WO2000043031A1 (en) 2000-07-27
NO328814B1 (no) 2010-05-18
US6663865B1 (en) 2003-12-16
HK1082690A1 (zh) 2006-06-16
EP1022027A1 (en) 2000-07-26

Similar Documents

Publication Publication Date Title
NO20034169D0 (no) MCH-antagonister og deres anvendelse ved behandling av fedme
NO20023043L (no) Substituerte oksazolidinoner og deres anvendelse innenfor feltet blodkoagulasjon
DE60017894D1 (de) Diaminothiazole und ihre verwendung zur inhibierung von proteinkinasen
NO20013577D0 (no) Tumor nekrose-faktorantagonister og deres anvendelse i endometrise
DK1212317T3 (da) Indolderivater og anvendelse deraf til behandling af osteoporose blandt andre anvendelser
DK1392292T3 (da) Pyranoindazoler og deres anvendelse til behandling af glaukom
NO20014858D0 (no) Anvendelse av CYP2D6 inhibitorer i kombinasjonsterapi
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
IL155772A0 (en) Piperidine mch antagonists and their use in the treatment of obesity
ATE447552T1 (de) Mch antagonisten und deren verwendung zur behandlung von fettleibigkeit
NO20014524D0 (no) Rekombinant IL-18 antagonister anvendelige i behandling av IL- 18 medierte forstyrrelser
NO20022680L (no) Farmasoytiske kombinasjoner og deres anvendelse ved behandling av gastrointestinale forstyrrelser
NO20030677L (no) Nye aporfinestere og deres anvendelse i terapi
DK1432417T3 (da) Substituerede imidazolforbindelser og deres anvendelse til behandling af cancer
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
DK1341786T3 (da) Substituerede derivater af aminofuran-2-yl-eddikesyre og aminothien-2-yl-eddikesyre og anvendelsen deraf til behandling af migræner og smerte
NO20020031D0 (no) Dihydrobenzodiazepiner og deres anvendelse ved behandling av dyslipidemi
NO20030547D0 (no) Azabicykliske derivater og deres terapeutiske anvendelse
DE60110802D1 (de) Heterozyklische-hydroximino-fluorene und ihre verwendung zur inhibierung von proteinkinasen
DK1228029T3 (da) Hydroxyicosatetraensyreanaloger og fremgangsmåder til deres anvendelse til behandling af öjentörhedslidelser
NO20040935L (no) Plaster for behandling av dysfunksjoner og forstyrrelser i negler.
NO20004406D0 (no) Aminoantracyklinonderivater og deres anvendelse i behandlingen av amyloidose
SE0001569D0 (sv) New compounds and their use in the treatment of alopecia
DK1418167T3 (da) Hydroxyicosatetraensyreanaloger og fremgangsmåder til deres anvendelse til behandling af öjentörhedslidelser
DK1278728T3 (da) Pyrrolidin- og piperidinderivater samt anvendelse deraf til behandling af neurodegenerative lidelser